$MRIN
Marin Software Inc

2024 Q1 Form 10-K Financial Statement

#000095017024019131 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $4.031M $4.350M $17.73M
YoY Change -12.04% -15.71% -11.43%
Cost Of Revenue $1.743M $2.132M $11.64M
YoY Change -46.2% -30.85% -9.07%
Gross Profit $2.288M $2.218M $6.096M
YoY Change 70.36% 6.74% -15.61%
Gross Profit Margin 56.76% 50.99% 34.38%
Selling, General & Admin $2.934M $3.052M $15.39M
YoY Change -32.72% -30.97% -11.51%
% of Gross Profit 128.23% 137.6% 252.48%
Research & Development $1.881M $1.614M $10.24M
YoY Change -36.06% -44.36% -13.5%
% of Gross Profit 82.21% 72.77% 167.9%
Depreciation & Amortization $2.000K $425.0K $1.720M
YoY Change -99.53% -1.16% -23.79%
% of Gross Profit 0.09% 19.16% 28.22%
Operating Expenses $4.815M $4.666M $28.90M
YoY Change -34.07% -36.27% -1.11%
Operating Profit -$2.527M -$2.448M -$22.81M
YoY Change -57.6% -53.32% 3.66%
Interest Expense -$137.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $104.0K $141.0K $739.0K
YoY Change -53.78% -31.88% -81.88%
Pretax Income -$2.423M -$5.607M -$22.07M
YoY Change -57.75% 10.94% 23.13%
Income Tax -$12.00K -$344.0K -$150.0K
% Of Pretax Income
Net Earnings -$2.411M -$5.263M -$21.92M
YoY Change -58.31% 2.83% 20.24%
Net Earnings / Revenue -59.81% -120.99% -123.61%
Basic Earnings Per Share -$0.80 -$1.24
Diluted Earnings Per Share -$0.80 -$0.29 -$1.24
COMMON SHARES
Basic Shares Outstanding 18.07M 18.04M 17.66M
Diluted Shares Outstanding 3.024M 17.66M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.563M $11.36M $11.36M
YoY Change -59.68% -59.36% -59.36%
Cash & Equivalents $9.563M $11.36M $11.36M
Short-Term Investments
Other Short-Term Assets $1.386M $1.548M $1.548M
YoY Change -16.15% -23.21% -23.21%
Inventory
Prepaid Expenses
Receivables $3.422M $3.864M $3.864M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.37M $16.78M $16.77M
YoY Change -51.16% -51.37% -51.37%
LONG-TERM ASSETS
Property, Plant & Equipment $118.0K $120.0K $2.032M
YoY Change -96.53% -96.27% -71.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $504.0K $508.0K $508.0K
YoY Change -11.11% -4.69% -4.69%
Total Long-Term Assets $2.235M $2.540M $2.540M
YoY Change -70.48% -66.53% -66.53%
TOTAL ASSETS
Total Short-Term Assets $14.37M $16.78M $16.77M
Total Long-Term Assets $2.235M $2.540M $2.540M
Total Assets $16.61M $19.32M $19.32M
YoY Change -55.11% -54.1% -54.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $609.0K $664.0K $664.0K
YoY Change -49.59% -34.32% -34.32%
Accrued Expenses $236.0K $376.0K $2.789M
YoY Change -60.73% -29.72% -24.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.042M $4.281M $4.281M
YoY Change -34.12% -30.6% -30.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $980.0K $1.001M $1.395M
YoY Change -3.64% -0.1% -56.42%
Total Long-Term Liabilities $980.0K $1.001M $1.395M
YoY Change -3.64% -0.1% -56.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.042M $4.281M $4.281M
Total Long-Term Liabilities $980.0K $1.001M $1.395M
Total Liabilities $5.022M $5.676M $5.676M
YoY Change -44.26% -39.42% -39.42%
SHAREHOLDERS EQUITY
Retained Earnings -$346.7M -$344.3M
YoY Change 5.65% 6.8%
Common Stock $359.2M $358.9M
YoY Change 0.61% 0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.58M $13.64M $13.64M
YoY Change
Total Liabilities & Shareholders Equity $16.61M $19.32M $19.32M
YoY Change -55.11% -54.1% -54.1%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$2.411M -$5.263M -$21.92M
YoY Change -58.31% 2.83% 20.24%
Depreciation, Depletion And Amortization $2.000K $425.0K $1.720M
YoY Change -99.53% -1.16% -23.79%
Cash From Operating Activities -$1.729M -$1.949M -$14.58M
YoY Change -53.17% -59.81% -19.6%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $296.0K $0.00
YoY Change -26.73% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$296.0K -$1.807M
YoY Change -100.0% -26.73% 2.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K -7.000K -209.0K
YoY Change -850.0% -100.54% -128.24%
NET CHANGE
Cash From Operating Activities -1.729M -1.949M -14.58M
Cash From Investing Activities 0.000 -296.0K -1.807M
Cash From Financing Activities -60.00K -7.000K -209.0K
Net Change In Cash -1.800M -2.252M -16.59M
YoY Change -57.56% -43.03% -13.12%
FREE CASH FLOW
Cash From Operating Activities -$1.729M -$1.949M -$14.58M
Capital Expenditures $0.00 $296.0K $0.00
Free Cash Flow -$1.729M -$2.245M -$14.58M
YoY Change -53.17% -57.26% -19.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001389002
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 mrin Financing Forgiveness Of Paycheck Protection Program Loan
FinancingForgivenessOfPaycheckProtectionProgramLoan
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-35838
CY2023 dei Entity Registrant Name
EntityRegistrantName
Marin Software Incorporated
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4647180
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
149 New Montgomery Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2023 dei City Area Code
CityAreaCode
415
CY2023 dei Local Phone Number
LocalPhoneNumber
399-2580
CY2023 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
MRIN
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
9100000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18067139
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
San Jose, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11363000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27957000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3864000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4521000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1548000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2016000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16775000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
34494000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3213000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1912000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3844000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
508000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
533000
CY2023Q4 us-gaap Assets
Assets
19315000
CY2022Q4 us-gaap Assets
Assets
42084000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
664000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1011000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2022Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3513000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1518000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1645000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4281000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6169000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
394000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2199000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1001000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002000
CY2023Q4 us-gaap Liabilities
Liabilities
5676000
CY2022Q4 us-gaap Liabilities
Liabilities
9370000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142857000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142857000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18064000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18064000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17226000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17226000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
358869000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
355996000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344251000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-322334000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-997000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-965000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19315000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42084000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17731000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20019000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
11635000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
12795000
CY2023 us-gaap Gross Profit
GrossProfit
6096000
CY2022 us-gaap Gross Profit
GrossProfit
7224000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6520000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6997000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10235000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11832000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8871000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10396000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3276000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Operating Expenses
OperatingExpenses
28902000
CY2022 us-gaap Operating Expenses
OperatingExpenses
29225000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-22806000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22001000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
739000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4079000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22067000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17922000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21917000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18227000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
79000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21949000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18148000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17656000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17656000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15891000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15891000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46258000
CY2022 mrin Stock Offering Cost
StockOfferingCost
95000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1333000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
434000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
37000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3668000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18227000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
79000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
238000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3105000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21917000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
CY2023 us-gaap Profit Loss
ProfitLoss
-21917000
CY2022 us-gaap Profit Loss
ProfitLoss
-18227000
CY2023 us-gaap Depreciation
Depreciation
19000
CY2022 us-gaap Depreciation
Depreciation
447000
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1701000
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1810000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1528000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2832000
CY2023 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
366000
CY2022 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
352000
CY2023 mrin Forgiveness Of Paycheck Protection Program Loan
ForgivenessOfPaycheckProtectionProgramLoan
0
CY2022 mrin Forgiveness Of Paycheck Protection Program Loan
ForgivenessOfPaycheckProtectionProgramLoan
-3117000
CY2023 mrin Impairment On Long Lived Assets
ImpairmentOnLongLivedAssets
3276000
CY2023 mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
-3000
CY2022 mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
-28000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-46000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-80000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
3006000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3555000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-414000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-70000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
48000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1037000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-73000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-183000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
102000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-353000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31000
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1466000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2786000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1528000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3177000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14583000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18137000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1807000
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1740000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1807000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1764000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1333000
CY2023 mrin Repayment Of Paycheck Protection Program Loan
RepaymentOfPaycheckProtectionProgramLoan
0
CY2022 mrin Repayment Of Paycheck Protection Program Loan
RepaymentOfPaycheckProtectionProgramLoan
-203000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
206000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
424000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
-3000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
34000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-209000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
740000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
61000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16594000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19100000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27957000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47057000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11363000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27957000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
85000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
168000
CY2022 mrin Financing Forgiveness Of Paycheck Protection Program Loan
FinancingForgivenessOfPaycheckProtectionProgramLoan
3117000
CY2023 us-gaap Stock Issued1
StockIssued1
6000
CY2022 us-gaap Stock Issued1
StockIssued1
37000
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. Organization and Summary of Significant Accounting Policies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Organization</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Marin Software Incorporated ("Marin", "Marin Software", or the “Company”) was incorporated in Delaware in March 2006. The Company provides enterprise marketing software for advertisers and agencies to integrate, align and amplify their digital advertising spend across the web and mobile devices. Offered as a unified software-as-a-service (“SaaS”) advertising management solution for search, social and eCommerce advertising, the Company’s platform helps digital marketers convert precise audiences, improve financial performance and make better decisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">References to “2023” and “2022” shall mean the years ended December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively. All amounts presented in these notes to the consolidated financial statements are in thousands, except where noted.</span></p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adjustment of Previously Issued Financial Statements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2023, the Company evaluated the aggregate effects of an error related to foreign exchange on intercompany accounts, which led to an adjustment to the presentation of the Company’s United States of America and International losses before provision for (benefit from) income taxes in the Company's income tax note disclosure. The adjustment had no other impact on the Company’s previously issued consolidated financial statements.</span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company is subject to uncertainties such as the impact of future events, economic and political factors and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations and if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect the allowances for doubtful accounts and customer revenue credits, and the accounting for income taxes.</span></p>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21917000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18227000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344251000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11363000
CY2023 us-gaap Restructuring And Related Activities Description
RestructuringAndRelatedActivitiesDescription
The 2023 Restructuring Plan resulted in the reduction of the Company's global employees by approximately 64 full-time employees during the second half of 2023, reducing its total headcount by approximately 37% from 172 as of June 30, 2023 to 108 as of December 31, 2023.
CY2021Q3 mrin Aggregate Offering Price
AggregateOfferingPrice
22800000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
909000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
653000
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
65000
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
69000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-137000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-127000
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
736000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
786000
CY2023 mrin Provision For Doubtful Accounts Reductions To Expense
ProvisionForDoubtfulAccountsReductionsToExpense
29000
CY2022 mrin Provision For Doubtful Accounts Reductions To Expense
ProvisionForDoubtfulAccountsReductionsToExpense
16000
CY2023 mrin Allowance For Doubtful Accounts Receivable Write Offs And Other Deductions
AllowanceForDoubtfulAccountsReceivableWriteOffsAndOtherDeductions
264000
CY2022 mrin Allowance For Doubtful Accounts Receivable Write Offs And Other Deductions
AllowanceForDoubtfulAccountsReceivableWriteOffsAndOtherDeductions
66000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
501000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
736000
CY2023Q4 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
12000
CY2022Q4 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
110000
CY2023 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
0
CY2022 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
0
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. The Company’s cash and cash equivalents are placed with high-credit-quality financial institutions and issuers, and at times exceed federally insured limits. The Company has not experienced any loss relating to cash and cash equivalents in these accounts. The Company performs periodic credit evaluations of its customers and generally does not require collateral.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023 and 2022, accounts receivable from one long-term strategic agreement with Google, as described in Note 2, accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, respectively, of the Company's total accounts receivable, net. Revenues, net from the same long-term strategic agreement accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total revenues, net for the years ended December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1906000
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1853000
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1701000
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1810000
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3276000
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3071000
CY2022Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
200000
CY2023 mrin Subscription Contracts Term
SubscriptionContractsTerm
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1015000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
268000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1283000
CY2023 mrin Unsatisfied Performance Obligation On Subscription Contract Term
UnsatisfiedPerformanceObligationOnSubscriptionContractTerm
P1Y
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17731000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20019000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17731000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20019000
CY2023 mrin Number Of New Customer
NumberOfNewCustomer
0
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1788000
CY2023 mrin Deferred Costs To Fulfill Contracts Expected Period Of Benefit
DeferredCostsToFulfillContractsExpectedPeriodOfBenefit
P30M
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3006000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3555000
CY2013Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
643000
CY2013Q1 mrin Percentage Of Outstanding Common Shares Increases
PercentageOfOutstandingCommonSharesIncreases
0.05
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
861000
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
425000
CY2023Q1 mrin Percentage Of Outstanding Common Shares Increases
PercentageOfOutstandingCommonSharesIncreases
0.05
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
31000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
31000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-21851000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18455000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21917000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18227000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17656000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17656000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15891000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15891000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2046000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2151000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-216000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
533000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22067000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17922000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
25000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-90000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
232000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-80000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
257000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-70000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
48000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-70000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
48000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4634000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3763000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2131000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6009000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
461000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-6000
CY2023 mrin Income Tax Reconciliation Uncertain Tax Position
IncomeTaxReconciliationUncertainTaxPosition
-31000
CY2022 mrin Income Tax Reconciliation Uncertain Tax Position
IncomeTaxReconciliationUncertainTaxPosition
-32000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-637000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1288000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
147000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
8000
CY2023 mrin Income Tax Reconciliation Other Permanent Differences
IncomeTaxReconciliationOtherPermanentDifferences
154000
CY2022 mrin Income Tax Reconciliation Other Permanent Differences
IncomeTaxReconciliationOtherPermanentDifferences
81000
CY2023 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
2269000
CY2022 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
0
CY2023Q4 mrin Ppp Loan Forgiveness
PppLoanForgiveness
0
CY2022Q4 mrin Ppp Loan Forgiveness
PppLoanForgiveness
-667000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-10000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-37000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41327000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37783000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9820000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9820000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1292000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
4165000
CY2023Q4 mrin Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
516000
CY2022Q4 mrin Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1037000
CY2023Q4 mrin Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Sharebased Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNoncurrent
983000
CY2022Q4 mrin Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Sharebased Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNoncurrent
1164000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
956000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2023Q4 mrin Capitalized Research And Development
CapitalizedResearchAndDevelopment
1709000
CY2022Q4 mrin Capitalized Research And Development
CapitalizedResearchAndDevelopment
912000
CY2023Q4 mrin Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsNoncurrent
68000
CY2022Q4 mrin Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsNoncurrent
133000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
56671000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55014000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
516000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1037000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
23000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
516000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1060000
CY2023Q4 mrin Deferred Tax Assets Liabilities Before Allocation Of Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeAllocationOfValuationAllowance
56155000
CY2022Q4 mrin Deferred Tax Assets Liabilities Before Allocation Of Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeAllocationOfValuationAllowance
53954000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56055000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53924000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
100000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
30000
CY2023 mrin Cumulative Change In Ownership Percentage
CumulativeChangeInOwnershipPercentage
0.50
CY2023 mrin Cumulative Change In Ownership Period
CumulativeChangeInOwnershipPeriod
P3Y
CY2023Q4 mrin State Enterprise Zone Credits
StateEnterpriseZoneCredits
1123000
CY2023 mrin State Enterprise Zone Credits Expiration Beginning Year
StateEnterpriseZoneCreditsExpirationBeginningYear
2024
CY2023Q4 mrin State Enterprise Zone Credits Unutilized
StateEnterpriseZoneCreditsUnutilized
2872000
CY2023 mrin State Enterprise Zone Credits Unutilized Expiration Beginning Year
StateEnterpriseZoneCreditsUnutilizedExpirationBeginningYear
2023
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2131000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6009000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
984000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
985000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9055000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
94000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8961000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
30000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
31000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8960000
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
368000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53658000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52837000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50262000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49624000
CY2023Q4 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
-3276000
CY2022Q4 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
0
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3213000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1720000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2257000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3276000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
872000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1460000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
376000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
535000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
192000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
464000
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
636000
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1016000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2022Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3513000
CY2023 mrin Wrote Off Credit Balance
WroteOffCreditBalance
443000
CY2022 mrin Wrote Off Credit Balance
WroteOffCreditBalance
0
CY2023 mrin Lease Liability Adjusted Its Right Of Use Assets
LeaseLiabilityAdjustedItsRightOfUseAssets
565000
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1842000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
3654000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1584000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
396000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1980000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
68000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1912000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1518000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
394000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1842000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
3974000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
161000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5015000
CY2022 us-gaap Sublease Income
SubleaseIncome
587000
CY2023 us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
the Company repaid the remaining outstanding balance of approximately $200 in February 2022.
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2726000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7500000
CY2020 mrin Stock Offering Cost
StockOfferingCost
463000
CY2020 mrin Weighted Average Sales Price Stock Offering
WeightedAverageSalesPriceStockOffering
2.92
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
658000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1643000
CY2019 mrin Stock Offering Cost
StockOfferingCost
210000
CY2019 mrin Weighted Average Sales Price Stock Offering
WeightedAverageSalesPriceStockOffering
2.82
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1186000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3025000
CY2021Q1 mrin Stock Offering Cost
StockOfferingCost
157000
CY2021Q1 mrin Weighted Average Sales Price Stock Offering
WeightedAverageSalesPriceStockOffering
2.68
CY2020 mrin Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorizedValue
0
CY2021Q3 mrin Remaining Shares Under Initial Registration Statement
RemainingSharesUnderInitialRegistrationStatement
37000000
CY2021Q3 mrin Additional Shares Under Initial Registration Statement
AdditionalSharesUnderInitialRegistrationStatement
3000000
CY2021Q3 mrin Aggregate Offering Price
AggregateOfferingPrice
40000000
CY2021Q3 mrin Aggregate Offering Price
AggregateOfferingPrice
22800000

Files In Submission

Name View Source Status
0000950170-24-019131-index-headers.html Edgar Link pending
0000950170-24-019131-index.html Edgar Link pending
0000950170-24-019131.txt Edgar Link pending
0000950170-24-019131-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrin-20231231.htm Edgar Link pending
mrin-20231231.xsd Edgar Link pending
mrin-ex21_1.htm Edgar Link pending
mrin-ex23_1.htm Edgar Link pending
mrin-ex31_1.htm Edgar Link pending
mrin-ex31_2.htm Edgar Link pending
mrin-ex32_1.htm Edgar Link pending
mrin-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mrin-20231231_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending